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Myt1l safeguards neuronal identity by actively 
repressing many non-neuronal fates
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Xuecai Ge4†, Sienna Drake3, Cheen Euong Ang1, Brandon M. Walker1, Thomas Vierbuchen1†, Daniel r. Fuentes1, 
philip Brennecke5†, Kazuhiro r. Nitta6†, Arttu Jolma6, lars M. Steinmetz5,7, Jussi Taipale6,8, Thomas C. Südhof2 & 
Marius Wernig1
Normal differentiation and induced reprogramming require 
the activation of target cell programs and silencing of donor cell 
programs1,2. In reprogramming, the same factors are often used to 
reprogram many different donor cell types3. As most developmental 
repressors, such as RE1-silencing transcription factor (REST) and 
Groucho (also known as TLE), are considered lineage-specific 
repressors4,5, it remains unclear how identical combinations of 
transcription factors can silence so many different donor programs. 
Distinct lineage repressors would have to be induced in different 
donor cell types. Here, by studying the reprogramming of mouse 
fibroblasts to neurons, we found that the pan neuron-specific 
transcription factor Myt1-like (Myt1l)6 exerts its pro-neuronal 
function by direct repression of many different somatic lineage 
programs except the neuronal program. The repressive function of 
Myt1l is mediated via recruitment of a complex containing Sin3b 
by binding to a previously uncharacterized N-terminal domain. In 
agreement with its repressive function, the genomic binding sites of 
Myt1l are similar in neurons and fibroblasts and are preferentially in 
an open chromatin configuration. The Notch signalling pathway is 
repressed by Myt1l through silencing of several members, including 
Hes1. Acute knockdown of Myt1l in the developing mouse brain 
mimicked a Notch gain-of-function phenotype, suggesting that 
Myt1l allows newborn neurons to escape Notch activation during 
normal development. Depletion of Myt1l in primary postmitotic 
neurons de-repressed non-neuronal programs and impaired 
neuronal gene expression and function, indicating that many 
somatic lineage programs are actively and persistently repressed 
by Myt1l to maintain neuronal identity. It is now tempting to 
speculate that similar ‘many-but-one’ lineage repressors exist for 
other cell fates; such repressors, in combination with lineage-specific 
activators, would be prime candidates for use in reprogramming 
additional cell types.
The combination of the three transcription factors Ascl1, Brn2, and 
Myt1l has been shown to reprogram fibroblasts and other somatic cells 
into induced neuronal (iN) cells7. Ascl1 acts as an ‘on-target’ pioneer 
factor to activate the neuronal program, whereas access of Brn2 to the 
chromatin is context-dependent and facilitates reprogramming later 
on8. Although Ascl1 alone is sufficient to generate iN cells, endoge-
nous Myt1l is induced during reprogramming and  exogenous Myt1l 
greatly improves the efficiency of reprogramming and the functional 
maturity of the resulting iN cells9,10. To investigate the role of Myt1l 
in reprogramming, we first raised antibodies specific for mouse and 
human Myt1l (Extended Data Fig. 1). Chromatin immunoprecipita-
tion followed by DNA sequencing (ChIP–seq) of endogenous Myt1l 
in fetal neurons (embryonic day (E) 13.5) and ectopic Myt1l in mouse 
embryonic fibroblasts (MEFs) two days after induction identified 3,325 
high-confidence Myt1l peaks that overlapped remarkably well between 
neurons and MEFs (Fig. 1a, Extended Data Fig. 2, Supplementary 
Table 1). Thus, similar to the pioneer factor Ascl1, Myt1l can access 
the majority of its cognate DNA binding sites even in a distantly related 
cell type. However, unlike Ascl1 targets8, the chromatin at Myt1l 
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Figure 1 | Context-independent target chromatin access of Myt1l.  
a, Genome-wide occupancy profiles of endogenous Myt1l in E13.5 mouse 
brains (n = 2) or overexpressed Myt1l with (n = 3) or without (n = 2) Ascl1 
and Brn2 (also known as Pou3f2) in MEFs two days after reprogramming. 
Corresponding regions are displayed across all datasets ± 2 kb from 
summits. b, Chromatin accessibility based on micrococcal nuclease 
digestion combined with sequencing (MNase–seq) signal in MEFs25 shows 
binding enrichment of Myt1l in open and Ascl1 in closed regions. c, Read 
densities of Ascl1 and Brn2 chromatin binding8 shows minor overlap at 
Myt1l-bound regions. d, The Myt1l AAGTT core motif (green arrow) 
is significantly enriched at bound sites across datasets. P = 1 × 10−43, 
E = 9.6 × 10−3. e, Pie chart indicates enrichment of high-confidence 
Myt1l-bound sites at gene promoters.
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targets is preferentially open (nucleosome-free) in fibroblasts (Fig. 1b). 
Hence, Myt1l appears to possess no pioneer factor activity, raising the 
question why the targets of a neuron-specific transcription factor are eas-
ily accessible in fibroblasts. As expected, there was little overlap between 
the target sites of Myt1l and Ascl1, and the chromatin binding of Myt1l 
was not strongly affected by Ascl1 and Brn2, indicating that these fac-
tors bind and function independent from each other (Fig. 1c, Extended 
Data Fig. 2d). Conversely, Brn2 targets were co-enriched for both Ascl1 
and Myt1l, suggesting that access of Brn2 to chromatin in fibroblasts is 
strongly directed by other factors8 (Extended Data Fig. 2d). De novo motif 
discovery identified an AAGTT motif that was significantly enriched in 
all Myt1l ChIP–seq experiments (Fig. 1d), which is similar to a previously 
proposed motif11,12. Remarkably, almost half of the Myt1l peaks were 
located in gene promoters, allowing us to associate them with likely target 
genes (Fig. 1e). Accordingly, we found histone marks associated with 
active promoters, such as H3K27ac and H3K4me3 enriched at Myt1l-
bound regions in MEFs (Extended Data Fig. 2e).
We next assessed the transcriptional effects of Myt1l by RNA 
sequencing (RNA-seq)8 (Fig. 2a, Extended Data Fig. 3, Supplementary 
Table 2). On average, Myt1l targets were significantly downregu-
lated in reprogramming fibroblasts, indicating that Myt1l may be 
a  transcriptional repressor that functions to silence the fibroblast 
 program during reprogramming. Indeed, gene set enrichment  analysis 
(GSEA) showed significant enrichment of MEF signature genes among 
the repressed Myt1l target genes (Fig. 2b, Supplementary Table 3). To 
functionally evaluate whether the repressive or activating properties 
of Myt1l drive iN cell reprogramming, we fused activating (VP64) or 
repressing (engrailed repressor; EnR) domains to a putative DNA-
binding fragment of Myt1l (410–623). The VP64–Myt1l fusion had 
a strong dominant-negative effect on Ascl1-mediated neuronal 
 conversion, whereas the EnR–Myt1l fusion significantly increased the 
number of cells expressing the neuron-specific class III β -tubulin TUJ1 
and Tau–eGFP compared to the inactive Myt1l fragment (410–623) 
(Fig. 2d, e). Thus, transcriptional repression is the predominant 
 function of Myt1l during neuronal reprogramming.
We then investigated whether the role of Myt1l might go beyond 
repressing the fibroblast identity. We found many Myt1l target genes 
with prominent non-neuronal developmental roles, and most of these 
Figure 2 | Myt1l target gene repression dominates induced 
neurogenesis. a, Repression of promoter-bound (transcription start 
site (TSS) − 5, + 2 kb) Myt1l targets (n = 1,798) dominates genome-
wide expression changes (n = 33,459) upon two days of reprogramming 
(P = 2.78 × 10−12, two biological replicates each)8. b, GSEA identified MEF 
signature among repressed Myt1l targets. NES, normalized enrichment 
score; FDR, false discovery rate. c, RNA-seq expression values of selected 
Myt1l targets at indicated time points during reprogramming, normalized 
to the mock sample; n = 2 (ref. 8). Myt1l represses several Notch, Wnt and 
proliferation factors. Many lineage specifiers are bound and repressed 
(ON→ OFF) or remain repressed (OFF→ OFF). FPKM, fragments per 
kilobase of transcript per million mapped reads. d, Immunofluorescence 
of iN cells derived from MEFs upon reprogramming for 14 days with 
Ascl1 and wild-type (WT) Myt1l or a non-functional zinc-finger fragment 
(Myt1l410–623) fused to a repressor (EnR) or activator (VP64); TUJ1 (red), 
DAPI staining (blue). e, Conversion efficiency of cells shown in d based 
on TUJ1-positive cells with neuronal morphology (black) or Tau–eGFP  
expression (white) show partial reprogramming using repressor fusion, 
with many Tau–eGFP-positive cells without neuronal morphologies.  
f, Immunofluorescence of MEFs upon reprogramming for 14 days with 
Ascl1 or MyoD without (mock) or with wild-type Myt1l; desmin (green), 
DAPI staining (blue). g, Induced muscle (iM) conversion efficiency 
of cells shown in f based on either desmin (black) or Myh expression 
(white) shows decreased muscle marker-positive cells upon addition of 
wild-type Myt1l. h, Western blot analysis of cells shown in f after 2 days 
of reprogramming using indicated antibodies (for gel source images see 
Supplementary Fig. 1). d–g, Scale bar 50 μ m, n = 3, error bars show s.d., 
t-test * P < 0.05.
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genes were downregulated or remained silent during reprogramming 
(Fig. 2c). Among the repressed targets were negative regulators of 
neurogenesis (Notch and Wnt pathway members, as well as Id3), key 
effectors of proliferation (such as Jak/Stat, Hippo, transforming growth 
factor (TGF) and Shh signalling pathway members), and transcrip-
tional regulators of several non-neuronal lineages. Strikingly, gene 
ontology analysis of Myt1l-repressed targets showed enrichment of 
terms associated with several non-neuronal processes (such as cartilage, 
heart and lung development), suggesting that Myt1l can repress not 
only the fibroblast program but also additional non-neuronal programs 
(Extended Data Fig. 3e). The gene expression signatures of MEFs, 
myocytes, hepatocytes and keratinocytes, but not of neurons, were 
strongly associated (odds ratio > 2) with repressed Myt1l target genes 
(Extended Data Fig. 3d, Supplementary Table 3). Remarkably, Myt1l 
motifs were depleted in promoters of neuronal compared to non- 
neuronal genes, whereas REST motifs were enriched to a similar extent 
in neuronal versus non-neuronal promoters (Extended Data Fig. 10h). 
Finally, Myt1l strongly inhibited the formation of myocytes when over-
expressed in primary myoblasts during differentiation or together with 
MyoD in fibroblasts (Fig. 2f–h, Extended Data Fig. 4). The combination 
of these correlative and functional data suggests that the main physio-
logical function of Myt1l is to repress many non-neuronal programs.
Next, we investigated how Myt1l accomplishes transcriptional 
 repression. To identify critical domains of Myt1l, we tested a collection 
of systematic Myt1l truncations that in combination with Ascl1 induced 
neuronal cell reprogramming assay (Fig. 3a, Supplementary Table 4). 
After ensuring that all Myt1l truncations were stable and localized to the 
nucleus, we found that a short, 423-amino-acid fragment was  sufficient 
to generate mouse and human iN cells that were molecularly and func-
tionally indistinguishable from those induced by full-length Myt1l 
(Fig. 3a–d, Extended Data Figs 5, 6). This Myt1l200–623 fragment 
contained a previously uncharacterized N-terminal domain and 
two zinc-fingers (ZF2 and ZF3), which are presumably responsible 
for DNA  interaction. Surprisingly, the conserved Myt1 domain was 
dispensable for reprogramming and only one of the three putative 
DNA-binding zinc-finger domain clusters was required. The presence 
of three zinc-finger clusters could imply a complex DNA interaction 
with multiple DNA sites simultaneously bound by different areas of the 
protein. However, mutating the central zinc-finger cluster to  abolish 
sequence-specific DNA-binding had no effect on Myt1l function13  
(Fig. 3a, b, Extended Data Fig. 7). In a fragment devoid of  additional 
zinc-fingers the same mutations completely abolished Myt1l function, 
suggesting that the zinc-finger clusters are functionally redundant. 
In vitro DNA  binding studies (using systematic evolution of  ligands 
by exponential enrichment (SELEX)) revealed that zinc-finger 
 clusters 2–3 and 4–6 enriched the same AAGTT motif, and ChIP–seq 
 experiments showed that full-length Myt1l and Myt1l200–623 bound the 
same genomic sites  during reprogramming (Fig. 3e, Extended Data 
Fig. 2, Supplementary Tables 1, 5). Thus, multiple DNA-interacting 
zinc- fingers are not required to engage DNA simultaneously but might 
simply increase the binding probability of Myt1l to its targets. Notably, 
downregulated Myt1l targets harbour significantly more AAGTT 
motifs than do upregulated targets, suggesting that binding affinity 
affects transcriptional output (Extended Data Fig. 3a).
The N-terminal domain preceding the central zinc-finger cluster 
was also critical for Myt1l function, because increased truncation of 
this domain resulted in progressive loss of reprogramming activity 
(Fig. 3a–d, Extended Data Fig. 5). As Myt1 family members have been 
reported to interact with Sin3b to mediate gene repression, we tested 
whether Myt1l can bind this repressive chromatin remodelling  complex 
during neuronal reprogramming14. We found that both full-length 
Myt1l and Myt1l200–623, but not Ascl1 or Brn2, could enrich Sin3b by 
immunoprecipitation (Fig. 3f). Sequence analysis revealed four highly 
conserved hydrophobic helical peptides within Myt1l200–500 that are 
similar to reported Sin3-interacting domains (SIDs) known to bind the 
paired amphipathic helix of Sin3b15 (Extended Data Fig. 8). To identify 
the SID of Myt1l we performed glutathione S-transferase (GST) pull-
down experiments and found that the most N-terminal predicted SIDs 
were necessary and sufficient to bind Sin3b, while no fragment bound 
the p300 co-activator (Fig. 3g, Extended Data Fig. 8). ChIP–seq exper-
iments showed that 80% of Myt1l targets, including the transcription 
factor Hes1, were co-bound by the repressive Sin3b–HDAC1  complex 
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Figure 3 | Characterization of neurogenic and repressive Myt1l 
domains. a, Truncation and mutation screen identifies Myt1l domains that 
are essential for induced neurogenesis from MEFs upon reprogramming 
for 14 days with Ascl1. Highlighted are nuclear localization signals (NLS), 
aspartic acid/glutamic acid-rich (Asp/Glu-rich), serine-rich (Ser-rich), 
Myt1 domains, coiled-coil domains, CCHC-type zinc-fingers (ZF) and 
CCHC-type zinc-finger mutants (mtZF). b, Conversion activity compared 
to wild-type Myt1l based on number of TUJ1-positive cells with neuronal 
morphology (black) or Tau–eGFP expression (white). n = 3, error 
bars show s.d., t-test * P < 0.005. c, Representative immunofluorescence  
of iN cells; TUJ1 (red), DAPI staining (blue), scale bar 50 μ m.  
d, Representative action potential (AP) traces of iN cells upon maturation 
for 21 days on mouse glia. e, SELEX DNA-binding experiments with 
Myt1l zinc-finger fragments enrich the same Myt1l AAGTT core motif 
(green arrows). f, Immunoprecipitation shows binding of endogenous 
Sin3b to full-length and minimal Myt1l in DNase-treated MEF cell lysates 
2 days after transgene overexpression. g, GST pull-down from MEF cell 
lysates identifies minimal Sin3b interaction region within functional 
Myt1l domain. h, Overlapping ChIP–seq chromatin occupancy profiles 
of overexpressed Myt1l (left), endogenous Sin3b (middle) and HDAC1 
(right) at Myt1l promoter target sites in MEFs 2 days after reprogramming 
induction. n = 2, for gel source images see Supplementary Fig. 1.
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early during reprogramming (Fig. 3h, Extended Data Fig. 8c). As 
expected, short hairpin RNA (shRNA)-mediated knockdown of Sin3b 
abolished iN cell formation, but this could also be due to additional 
roles of Sin3b16 (Extended Data Fig. 8e–g).
Like its family member Myt117,18, Myt1l targets the Notch signal-
ling pathway on multiple levels (Fig. 2c). Notch signalling inhibits 
the differentiation of neural progenitor cells through Hes1-mediated 
repression of proneuronal factors such as Ascl1, but it remains unclear 
how  newborn neurons escape this inhibition19,20. We found that Myt1l 
largely inhibited the negative effect of Notch intracellular domain 
(NICD) on neuronal reprogramming and reduced the protein levels 
of Hes1 (Fig. 4a, b, Extended Data Fig. 9a). Chemical inhibition of 
Notch using N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenylglycine 
t-butyl ester (DAPT) enhanced Ascl1-mediated Tau–eGFP induction, 
but did not further enhance reprogramming induced by Ascl1 together 
with Myt1l (Extended Data Fig. 9b). Combined overexpression of Ascl1 
and Hes1 in MEFs not only counteracted neuronal reprogramming but 
also decreased Ascl1 levels without inducing neural stem-cell markers 
(Extended Data Fig. 9b, c). Surprisingly, Hes1 overexpression decreased 
not only Ascl1 protein but also the transgenic Ascl1 mRNA, suggest-
ing previously unrecognized post-transcriptional regulation of Ascl1 
expression (Extended Data Fig. 9d). Addition of Myt1l could not rescue 
the reprogramming block induced by Hes1 overexpression, whereas 
it could rescue the NICD-mediated reprogramming block, demon-
strating that Myt1l-mediated Notch inactivation is primarily caused 
by direct repression of Hes1 transcription.
To investigate the physiological function of Myt1l during normal 
neurogenesis, we performed in utero electroporation of Myt1l-shRNA–
GFP constructs into the forebrains of mice at E13.5. Myt1l depletion 
led to a substantial reduction in the number of electroporated cells 
in the cortical plate two days later, with a corresponding increase 
in GFP-positive cells in the ventricular and subventricular zones 
(Fig. 4e). Moreover, we found a reduced fraction of Map2+ mature 
 neuronal cells among GFP+ cells, and there was a compensatory 
increase in GFP+ apical (Sox2+) and basal (Tbr2+) progenitors, 
 indicating that acute Myt1l depletion impairs neurogenesis in vivo  
(Fig. 4f–h). Neural stem cells (NSCs) exhibit oscillatory Hes1 expression 
that triggers anti-phasic expression of proneural factors such as Ascl119. 
To test whether Myt1l could repress Hes1 and thereby  trigger Ascl1 
induction and neuronal differentiation, we overexpressed Myt1l200–
623 in mouse NSCs and observed increased neuronal  differentiation 
(Fig. 4c, Extended Data Fig. 9f). Western blot analysis of NSCs 
 maintained in proliferating conditions with fibroblast growth factor 
(Fgf) and epidermal growth factor (Egf) showed that overexpres-
sion of Myt1l200–623 strongly decreased Hes1 and slightly increased 
Ascl1 protein levels (Fig. 4d). Remarkably, even exogenous Ascl1 
Figure 4 | Myt1l represses Notch and Hes1 activity to promote 
neurogenesis. a, Fraction of Tau–eGFP+ iN cells derived from MEFs 
upon reprogramming for 7 days with Ascl1 and wild-type Myt1l, Notch 
intracellular domain (NICD) or a combination, determined by flow 
cytometry. n = 6, error bars show s.d., t-test * P < 0.05. b, Western blot 
analysis of cells shown in a using indicated antibodies. c, Neuronal 
differentiation efficiency of mouse NSCs upon overexpression of reverse 
tetracycline-transactivator (rtTA; mock) or rtTA and Myt1l200–623 for 
7 days based on TUJ1+ cells with neuronal morphology. n = 3, error 
bars show s.d., t-test * P < 0.05. d, Western blot analysis of proliferating 
NSCs upon 7 days of induction of rtTA (mock) alone or with Myt1l200–623 
using indicated antibodies. e, Myt1l knockdown cells exhibit cell 
positioning defects in utero. Control or Myt1l shRNA constructs  
co-expressing GFP were electroporated into E13.5 embryonic mouse 
brains, and the mice were analysed at E15.5. The percentage of GFP+  
cells in each region is shown. CP, cortical plate; IZ, intermediate zone;  
SVZ/VZ, subventricular zone/ventricular zone (n = 8). f–h, Myt1l  
knockdown leads to in vivo neurogenesis defects. Cortices electroporated 
in e were examined at E15.5 by staining with antibodies against Map2, 
Tbr2 or Sox2 and the percentage of the GFP+ cells that were also positive 
for the corresponding markers are shown. n = 5 for shControl and shMyt1l 
#2, n = 4 for shMyt1l #1. Scale bar, 25 μ m; error bars show s.e.m., t-test  
* P < 0.05, * * P < 0.005, * * * P < 0.0005. For gel source images  
see Supplementary Fig. 1.
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protein became stabilized upon Myt1l overexpression in MEFs dur-
ing reprogramming, further suggesting that Hes1 also blocks Ascl1 
post-transcriptionally (Extended Data Fig. 9e). In summary, these 
findings show that Myt1l can render cells insensitive to Notch signalling 
and provide a molecular explanation of how newborn neurons can 
overcome the Notch anti-differentiation stimulus.
Last, we investigated whether Myt1l also represses many non- 
neuronal programs in primary neurons. RNA-seq of cultured hip-
pocampal neurons showed that shRNA-mediated Myt1l depletion led 
to de-repression of Myt1l target genes, such as Notch and Wnt pathway 
members, and overall induced gene ontology terms characteristic of 
non-neuronal tissues, including cartilage and heart (Extended Data 
Fig. 10i, j). Fibroblast-, keratinocyte- and hepatocyte-specific gene 
signatures were more highly enriched among induced than repressed 
genes (Extended Data Fig. 10g). Importantly, the de-repression of 
non-neuronal programs was associated with loss of neuronal gene 
expression and functional properties (Extended Data Fig. 10a–f). 
Moreover, sequence analysis showed that, in contrast to REST, Myt1l 
motifs are substantially depleted at neuronal gene promoters, further 
supporting the ‘many-but-neuronal’ repressive function of Myt1l 
(Extended Data Fig. 10h).
In this study, we discovered a new kind of transcriptional  repressor. 
Unlike conventional repressors that inhibit specific lineages, such as 
REST and Groucho, Myt1l appears to block a multitude of differen-
tiation programs and lineage identities, but not the neuronal lineage. 
In combination with activating lineage master regulators such as 
Ascl1, the molecular repressor Myt1l acts in a perfect complementary 
 fashion to enable cell fate determination. Similar pairs of activating and 
 repressing transcription factors may yield optimal reprogramming for 
other  lineages. Finally, our data suggest that the physiological function 
of Myt1l is to establish and maintain the identity of neurons. Myt1l is 
the only known transcription factor that is specifically expressed in 
all neurons throughout life, indicating that active repression of non- 
neuronal programs is critical for maintaining the neuronal identity6. 
It is possible that the various Myt1l mutations recently identified in 
autism, schizophrenia, major depression, and intellectual disability 
may affect the neuronal maintenance function of Myt1l rather than 
 neurogenesis21–24. If this were the case, it might provide the opportunity 
to carry out curative interventions even in adult patients.
Online Content Methods, along with any additional Extended Data display items and 
Source Data, are available in the online version of the paper; references unique to 
these sections appear only in the online paper.
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No statistical methods were used to predetermine sample size and the  investigators 
were not blinded to allocation during experiments and outcome assessment.
Reprogramming and efficiency calculation. Third-passage wild-type, heterozy-
gous Tau–eGFP knock-in MEFs or human embryonic fibroblasts were infected 
with indicated lentivirus (available from us through Addgene or specified in 
Supplementary Table 4) in MEF medium containing 8 μ g/ml polybrene (Sigma) 
for 16–20 h. Cells were switched into fresh MEF medium containing 2 μ g/ml 
doxycycline (Sigma) to induce transgene expression for 2 days. On day 3 cells were 
switched into N3 medium (DMEM/F12) containing N2 supplement, B27, 20 μ g/ml 
insulin, penicillin/streptomycin (all from Invitrogen) and doxycycline to continue 
reprogramming. The medium was changed every 2–3 days for the duration of the 
reprogramming. To calculate the efficiency of neuronal induction, the total number 
of Tau–eGFP- and/or TUJ1-expressing cells with complex neurite outgrowth (cells 
having a spherical cell body and at least one thin process three times the size of 
their cell body) was counted manually 7 or 14 days after transgene induction by 
immunofluorescence microscopy. To calculate the efficiency of myocyte-like cell 
induction, the total number of desmin- and Myh-expressing cells was counted 
manually 14 days after transgene induction by immunofluorescence microscopy. 
The quantification was based on the average number of neuronal or myocyte-like 
cells present in a minimum of 30 randomly selected 20× fields of view from at 
least three biological replicates. The number of reprogrammed cells was then 
normalized either to the number of reprogrammed cells in the control condition 
or to the total number of cells determined by DAPI staining. Tau–eGFP-expressing 
cells in Fig. 4a and Extended Data Fig. 9b were quantified using a LSRFortessa 
fluorescence-activated cell analyser (BD Biosciences), on the basis of the average 
number of TauEGFP-positive cells detected in 60,000–120,000 analysed cells from 
at least three to six biological replicates.
In utero electroporation. All animal protocols have been IRB approved by Stanford 
University. For in utero electroporation, pregnant CD-1 mice (Charles River) were 
deeply anaesthetized with isoflurane (Henry Schein), after which the uterine horns 
were carefully exposed through a midline abdominal incision. pSico constructs 
encoding both GFP and indicated shRNA-oligos from the same DNA plasmid 
(1–2 μ l of 2 μ g/μ l) were diluted in PBS containing 0.01% fast green (Sigma) as a 
tracer and injected in utero into the lateral ventricle of mouse embryos at E13.5 
using a micropipette made from G-1 glass capillaries (Narishige). After injection, 
the embryo in the uterus was placed in a 5-mm platinum tweezertrode and five 
50-ms square pulses of 25 V with 950-ms intervals were applied with an ECM 
830 electroporation system (both from Harvard Apparatus). We performed 
randomized electroporations of control or Myt1l-targeting shRNAs in the right 
and left uterine horns of several pregnant mice to avoid any technical effect on the 
experimental outcome. Then, uterine horns were placed back into the abdominal 
cavity, and the abdominal wall of the pregnant mouse was sutured. Embryonic 
brains were harvested and dissected 2 days (E15.5) after electroporation for sub-
sequent immunofluorescence processing and analysis. Brain sections were then 
co-stained with the indicated antibodies and anti-GFP to identify electroporated 
cells expressing the indicated knockdown constructs. The distribution of GFP-
positive cells in each layer and the fraction of GFP and marker double-positive 
cells were determined by dividing the number of GFP-positive cells in each layer 
or the total number of double-positive cells by the total number of GFP-positive 
cells in the entire section, respectively.
Electrophysiology. Electrophysiological recordings were performed from 
mouse primary hippocampal neurons 14 days after in vitro culture and 11 days 
after shRNA infection or on MEF-derived induced neuronal (MEF-iN) cells 
21 days after transgene induction and 14 days after co-culturing on glia, following 
previous protocols9. In brief, action potentials were recorded using a current-clamp 
configuration with pipette solution containing (in mM): 130 KMeSO3, 10 NaCl, 
2 MgCl2, EGTA 0.5 (for MEF-iN), 1 (for primary cultures), CaCl2 0.16 (for 
MEF-iN), 0.1 (for primary cultures), 4 Na2ATP, 0.4 NaGTP, 14 Tris-creatine 
 phosphate, and 10 HEPES-KOH (pH adjusted to 7.3, 310 mOsm). The bath 
 solution contained (in mM): 140 NaCl, 5 KCl, CaCl2 2 (for MEF-iN), 3 (for 
 primary cultures), 1 MgCl2, 10 glucose, and 10 HEPES-NaOH (pH 7.4). Membrane 
 potentials were kept around − 60 mV using small holding currents, and step 
 currents were injected to elicit action potentials. Recordings of the intrinsic and 
active membrane properties were performed in the presence of 50 μ M picrotoxin, 
10 μ M CNQX and 50 μ M d-AP5 in the bath solution (all from Tocris). The  synaptic 
current recordings were performed in voltage-clamp mode with internal solution 
containing (in mM): 135 CsCl2, 1 EGTA, 4 Na2ATP, 1 Na-GTP, 1 QX-314, and 10 
HEPES-NaOH (pH adjusted to 7.4, 310 mOsm). α -Amino-3-hydroxy-5-methyl-
4-isoxazolepropionic acid (AMPA)-receptor excitatory postsynaptic currents 
(EPSCs) were pharmacologically isolated by application of 50 μ M picrotoxin, and 
were subsequently blocked by addition of 50 μ M CNQX. Evoked synaptic responses 
were triggered by 1-ms, 1-mA current injection through a local  extracellular 
electrode (FHC concentric bipolar electrode) with a Model 2100 Isolated 
Pulse Stimulator (A-M Systems). All recordings were performed in whole-cell 
configuration using a Multiclamp 700B amplifier (Molecular Devices). All average 
data were analysed from three or more biological replicates using Clampfit 10.4 
(Axon Instruments).
Cell line generation and maintenance. MEFs were isolated from wild-
type or heterozygous Tau–eGFP knock-in mouse embryos at E13.5 (Jackson 
Laboratories) after removal of all neural cell-containing tissues. Mouse glial 
cells were  isolated from forebrains of wild-type mice (Jackson Laboratories) 
at postnatal day 2. Both cell types were maintained in MEF medium (DMEM; 
Invitrogen) containing 10% cosmic calf serum (CCS; Hyclone), beta- 
mercaptoethanol (Sigma), non-essential amino acids, sodium pyruvate and 
penicillin/ streptomycin (all from Invitrogen) and passaged three times before 
experiments. Mouse NSCs were isolated from forebrains at E13.5 or cortex at 
E14.5 of wild-type mouse embryos. The cells were maintained on PO-laminin-
coated tissue culture dishes or as neurospheres in proliferation medium 
(DMEM/F12) containing N2 or B27 supplement, penicillin/streptomycin (all 
from Invitrogen), and 20 ng/ml Egf, 10 ng/ml Fgf (both from Peprotech). Cells 
were infected and kept in proliferation medium for 7 days after transgene 
induction using doxycycline or changed 1 day after infection to N3 medium 
(DMEM/F12) containing N2 supplement, B27, 20 μ g/ml insulin, penicillin/ 
streptomycin (all from Invitrogen), 1% fetal bovine serum (FBS; Hyclone), and 
doxycycline to induce differentiation for 7 days. For primary neuronal cultures, the 
hippocampus of P0 wild-type mouse pups was isolated and cultured on Matrigel-
coated plates (Corning) in MEM supplemented with B27, glucose, transferrin and 
5% FBS. Two days after plating, the medium was supplemented with 2 mM Ara-C 
(Sigma) as described previously26. Primary myoblasts were isolated and cultured 
on collagen-coated plates (Corning) in DMEM supplemented with 20% FBS 
and penicillin/streptomycin (Invitrogen) as described27. One day after infection 
and transgene induction using doxycycline, primary myoblasts were transferred 
into DMEM containing penicillin/streptomycin and 5% horse serum (all from 
Invitrogen) to induce muscle differentiation for 4 days. The medium for all cells 
was changed every 2–3 days for the duration of the experiment and all cells were 
grown at 37 °C and 5% CO2. Cells tested negative for mycoplasma contamination.
Virus production and infection. Lentiviruses were produced by  transfection 
of lentiviral backbones containing the indicated transgenes together with 
third- generation packaging plasmids into HEK293 cells following the Trono 
laboratory protocol28. Viruses were concentrated from culture supernatant by 
ultra- centrifugation (23,000 rpm, 2 h, 4 °C) and cells were infected with three 
 different viral titres. Infected cell populations that were used for reprogramming 
and genomic analysis were verified by immunofluorescence to contain approxi-
mately 70–90% transgene-positive cells 2 days after induction by immunofluo-
rescence microscopy.
Plasmid constructs. DNA constructs were generated by PCR amplification with 
Phusion polymerase followed by restriction digest using the indicated enzymes 
and ligation with T4 DNA ligase (all from NEB). Site-directed mutations of Myt1l 
zinc-fingers 2–3 were generated using the QuikChange Multi Site-Directed 
Mutagenesis Kit (Agilent Technologies) following the manufacturer’s instructions. 
A complete list of all constructs and primers generated in this study can be found 
in Supplementary Tables 4 and 6.
Protein expression and purification. Proteins for immunization and GST pull 
downs were expressed in E. coli Rosetta DE3 (Novagen). All His- and His-GST-
tagged Myt1l fragments were purified under native conditions using Ni-NTA 
Agarose (Qiagen) and eluted in bacterial lysis buffer containing (in mM): 20 Tris 
pH 7.5, 500 NaCl, 1 MgCl2 supplemented with 400 imidazole (all from Sigma). 
Eluted proteins were dialysed overnight against phosphate buffered saline (PBS) 
and supplemented with 10% glycerol (both from Sigma) before use or storage 
at − 80 °C.
Antibodies. Polyclonal antibodies against Myt1l were raised in rabbits using 
recombinant His-tagged mouse mmMyt1l amino acids 171–420. Immune sera 
were affinity purified against the antigen immobilized on Affigel (Bio-rad) and 
eluted in buffer containing (in mM): 100 glycine pH 2.7, 150 NaCl followed by 100 
glycine pH 2.2, 150 NaCl. 50 ml anti-Ascl1 hybridoma supernatant, 2.5 mg affinity 
purified anti-Myt1l antibody, and mouse or rabbit control IgG (Sigma) were each 
coupled to 250 μ l protein A sepharose (GE Healthcare) using buffer containing 
(in mM): 20 dimethyl pimelimidate in 200 Na2B4O7 pH 9, blocked with 1,000 Tris 
pH 8, followed by 200 ethanolamine pH 8, washed with 200 Na2B4O7 pH 9, washed 
with 200 glycine pH 2.2, 150 NaCl, and finally washed extensively using PBS (all 
from Sigma). A complete list of all primary antibodies used in this study can be 
found in Supplementary Table 7. Secondary Alexa-conjugated antibodies were used 
at 1:2,000 (all from Invitrogen), secondary HRP-conjugated antibodies were used 
at 1:5,000 (all from Jackson Immunoresearch) and secondary IRDye-conjugated 
antibodies were used at 1:5,000 (all from LI-COR).
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Immunofluorescence. Cultured cells were washed with PBS and fixed using 4% 
paraformaldehyde (PFA; Affymetrix) for 10 min. Cells were then permeabilized in 
0.5% Triton X-100 (Sigma) in PBS for 5 min, blocked in a solution of PBS containing 
2% bovine serum albumin (BSA; Sigma) for 1 h, and incubated with primary anti-
body for 1 h at room temperature or overnight at 4 °C. Cells were washed three 
times for 15 min using blocking solution before being incubated for 30 min with 
secondary antibodies. For DNA staining, 100 ng/ml DAPI was added to the last 
washing step (Invitrogen). Embryonic mouse brains were dissected and immer-
sion fixed in 4% PFA overnight; adult mice were transcardially perfused first with 
PBS followed by ice-cold 4% PFA, then the brains were isolated and post-fixed 
in 4% PFA overnight. After fixation, embryonic and adult brains were cryopro-
tected overnight in 30% sucrose in PBS. Embryonic brains were embedded in 
OCT compound (Sakura), frozen in dry ice, sectioned on a cryostat at 20 μ m and 
mounted on glass slides. Adult brains were sectioned at 40 μ m using a freezing 
 sliding microtome. For immunofluorescence, mounted (embryonic) or free- 
floating (adult) sections were washed in potassium phosphate buffer (KPBS). They 
were then incubated in KPBS with 0.25% Triton-X100 and 5% normal donkey and 
goat serum (pre-incubation solution; both from Jackson Immunoresearch) for 
1 h at room temperature and incubated with primary antibody in pre-incubation 
solution overnight at 4 °C. Following washes in KPBS with 0.25% Triton-X100, 
sections were incubated with secondary antibodies and Hoechst (Invitrogen) in 
pre-incubation solution for 2 h at room temperature. After final washes in KPBS, 
free-floating sections were mounted on gelatin-coated slides and sealed using 
glycerol-based mounting medium. Microscopy images were obtained using a 
DM6000 B microscope equipped with a 20 × HCX PL air objective (NA 0.4) and 
a DFC365 FX digital camera (all from Leica).
Immunoprecipitation experiments. For each immunoprecipitation, 20 × 106 MEF 
cells infected with the indicated transgenes 2 days after induction were lysed in 
1 ml cell lysis buffer containing (in mM): 0.5% Tween-20, 50 Tris pH 7.5, 2 EDTA, 
1 DTT, 1 PMSF, 5 NaF (all from Sigma), and complete protease inhibitor (Roche) 
for 15 min at 4 °C. Nuclei were pelleted by centrifugation (3,200 rpm, 1 min, 4 °C) 
and resuspended in 1 ml NP-40 lysis buffer containing (in mM): 0.5% NP-40, 50 
Tris pH 8, 150 NaCl, 2 EDTA, 1 DTT, 1 PMSF, 5 NaF, 5 μ g/ml cytochalasin B (all 
from Sigma), complete protease inhibitor (Roche), and benzonase (Merck). Debris 
was removed by centrifugation (14,000 rpm, 10 min, 4 °C) and nuclear lysate was 
pre-cleared by incubation with 15 μ l uncoupled protein A beads before addition of 
15 μ l antibody-coupled beads for 2 h at 4 °C. After binding, the beads were washed 
extensively in NP-40 lysis buffer and bound proteins were eluted with SDS–PAGE 
sample buffer.
GST pull-down experiments. For each pull-down, 20 × 106 MEF cells were lysed 
in 1 ml cell lysis buffer containing (in mM): 0.5% Tween-20, 50 Tris pH 7.5, 2 
EDTA, 1 DTT, 1 PMSF, 5 NaF (all from Sigma), and complete protease inhibitor 
(Roche) for 15 min at 4 °C. Nuclei were pelleted by centrifugation (3,200 rpm, 
1 min, 4 °C) and resuspended in 0.5 ml cell lysis buffer containing 500 mM NaCl, 
5 μ g/ml cytochalasin B (Sigma), and benzonase (Merk). Debris was removed by 
centrifugation (14,000 rpm, 10 min, 4 °C) and nuclear lysate was diluted with 
cell lysis buffer 1:1.25 (200 mM NaCl c.f.). 50 μ g of GST alone or GST-tagged 
Myt1l fragments were incubated with 20 μ l glutathione sepharose 4B beads 
(GE Healthcare) in PBS supplemented with 2 μ g/ml BSA (Sigma) and complete 
protease inhibitor (Roche) for 1 h at 4 °C. Beads were then washed extensively in 
cell lysis buffer containing 200 mM NaCl before addition of diluted nuclear lysate 
and incubation for 2 h at 4 °C. After binding the beads were washed extensively 
in cell lysis buffer containing 200 mM NaCl, and bound proteins were eluted with 
SDS–PAGE sample buffer.
ChIP-seq and computational analysis. For each ChIP-seq experiment, either 
four brains from wild-type E13.5 mouse embryos or 20–40 × 106 primary cells 
2 days after transgene induction were cross-linked using 1% formaldehyde (EMS) 
for 10 min followed by lysis in 1 ml swelling buffer containing (in mM): 0.5% 
NP-40, 5 HEPES pH 7.9, 85 KCl, 1 DTT, 1 PMSF (all from Sigma), and complete 
protease inhibitors (Roche) for 20 min on ice. Nuclei were pelleted by centrifu-
gation (3,200 rpm, 1 min, 4 °C) and lysed in 1 ml lysis buffer containing (in mM): 
1% SDS, 50 Tris pH 8, 10 EDTA, 1 DTT, 1 PMSF (all from Sigma), and complete 
protease inhibitors (Roche) for 10 min on ice. Chromatin was sheared using a 
Bioruptor sonicator (Diagenode) until DNA was fragmented to 200–500 bp 
followed by 1:4 dilution with buffer containing (in mM): 1% Triton X-100, 
20 Tris pH 8, 2 EDTA, 150 NaCl, 1 PMSF (all from Sigma), and complete protease 
inhibitors (Roche). Diluted lysate was pre-cleared by incubation with 15 μ l Staph 
A cells or 50 μ l protein A beads before addition of antibody (20 μ g Sin3b or 50 μ g 
HDAC1) or 50 μ l antibody-coupled beads (Myt1l) overnight at 4 °C. After binding, 
the antibody-coupled beads were washed extensively in wash buffer containing 
(in mM): 1% NP-40, 0.05% SDS, 20 Tris pH 8, 250 NaCl, 2 EDTA (all from Sigma), 
and complete protease inhibitors (Roche). The reactions with uncoupled antibody 
were supplemented with 15 μ l Staph A cells washed extensively in the following 
three wash buffers containing (in mM): 1% Triton X-100, 0.1% SDS, 20 Tris pH 8, 
150 NaCl, 2 EDTA; 1% Triton X-100, 0.1% SDS, 20 Tris pH 8, 500 NaCl, 2 EDTA; 
and 1% NP-40, 1% DOC, 10 Tris pH 8, 250 LiCl, 1 EDTA. After washing, the bound 
fraction was eluted in 100 μ l elution buffer containing (in mM): 1% SDS, 50 Tris 
pH 8, 10 EDTA, 100 PMSF and reversed cross-linked by overnight incubation at 
65 °C. The isolated DNA was RNase (NEB) treated and purified using QIAGEN 
columns. Libraries were generated using the NEBNext ChIP–seq Library Prep 
Master Mix Set for Illumina (NEB) and single-end sequencing reads (50 bp) were 
generated on HiSeq 2500 platforms (Illumina). ChIP–seq reads are available on 
NCBI GEO under accession number GSE72121. Raw reads were mapped to mouse 
reference genome GRCm38/mm10 using bowtie2 (version 2.2.3) and allowing a 
maximum of one mismatch29. Peaks for each sample were called using MACS2 
algorithm (version 2.0.10.20131216)30 using the shift size values calculated from 
the run_spp.R script from the SPP peak caller31. High quality peaks were  identified 
using IDR2 (https://github.com/nboley/idr). A negative control ChIP was 
performed as described above using the Myt1l antibody on rtTA-only infected 
cells. Any rtTA peak that overlapped a peak in any other condition by greater 
than 50% was excluded from the final analyses. Heatmaps of ChIP–seq signals 
were  generated around peak summits (± 2 kb region) using 25-bp sliding  windows 
with the HOMER suite (version 4.7)32. Read histograms, motif analysis, peak 
annotation, and gene ontology analysis were also performed using HOMER and 
PHANTER33. Both Bedtools and SAMtools were used for file processing and 
format  conversions34,35. Differential Myt1l localization was determined using 
the DiffBind R package36. All ChIP–seq data were analysed from two or three 
biological replicates.
MNase–seq analysis. To assess nucleosome occupancy at candidate regions, we 
used a previously reported MEF MNase–seq data set (GSE40896)25. The raw 
reads were mapped to GRCm38/mm10 using bowtie (version 1.1.1) allowing one 
 mismatch as described37. Histograms of read densities for the Myt1l peaks and 
Ascl1 peaks8 (lifted over to mm10) were compiled using HOMER.
Transcript analysis using RNA-seq and quantitative PCR. RNA was isolated 
using Trizol (Invitrogen) and treated with DNase (NEB). For RNA-seq, libraries 
were prepared following the dUTP protocol38 and paired-end sequencing reads 
(100 bp) were generated on HiSeq 2500 platforms (Illumina). RNA-seq reads are 
available on NCBI GEO under accession number GSE72121. Raw reads were 
mapped to mouse reference genome GRCm38/mm10 using TopHat2 (version 
2.0.10)39 and transcript assembly and differential expression determined using 
cufflinks (version 2.1.1) according to the cuffquant pipeline40. CummeRbund 
was used to generate expression scatterplots and cluster3 and treeview were 
used to  generate heatmaps41–43. GSEA was performed using all genesets in the 
MsigDB database (GSE14012)44,45, including a MEF gene signature that was 
compiled by taking the genes that were enriched by a factor of 10 in the MEF 
condition  compared to the induced neuronal condition from the raw RNA-seq 
data in ref. 8 (Supplementary Table 3). The significance of GSEA profiles was 
determined by an FDR <  0.25, as described45. Cell-type-specific gene signatures 
were derived from the top 10% of the genes unique to a particular cell type46–49, 
excluding any genes common amongst four out of five sets to exclude housekeeping 
genes (Supplementary Table 3). Odds ratio analysis was performed using the 
GeneOverlap R package (version 1.6.0)50. For quantitative PCR, RNA was reverse 
transcribed using Superscript II (Invitrogen) following the manufacturer’s 
 instructions. Quantitative real time PCR was performed from cDNA templates 
using the SYBR Green PCR master mix and a 7900HT Fast Real-Time PCR System 
(Applied Biosystems). Transcript levels were determined after normalization 
against GAPDH using the Relative Expression Software Tool (REST)51. A complete 
list of real-time PCR primers used in this study can be found in Supplementary 
Table 6. All RNA-seq data were analysed from two biological replicates.
SELEX. Constructs encoding Myt1l DNA-binding domains were generated by gene 
synthesis (codon optimized, Genscript) as indicated in Supplementary Table 5. 
Clones were transferred to an N-terminal thioredoxin hexahistidine bacterial 
expression vector (pETG-20A-SBP; ref. 52) by a Gateway LR reaction (Invitrogen). 
Proteins were produced in the E. coli Rosetta DE3 pLysS (Novagen), and purified, 
and HT-SELEX analyses were performed as described previously53. After each 
SELEX cycle, the selection ligands were sequenced using HiSeq 2000 platforms 
(Illumina), and PWM models generated using the seed, cycle and multinomial 
model reported in Supplementary Table 5 as described here53.
Data availability statement. ChIP and RNA-seq data have been deposited in 
the NCBI GEO database under accession number GSE72121. All other data are 
available from the corresponding author upon reasonable request.
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Extended Data Figure 1 | Myt1l antibody design and characterization.  
a, Schematic of mouse Myt1 family members mmMyt1 (Q8CFC2), 
mmMyt1l (P97500) and mmSt18 (A5LFV3) as well as human hsMyt1l 
homologue (Q9UL68). Highlighted are the nuclear localization signals 
(NLS), aspartic acid/glutamic acid-rich (Asp/Glu-rich), serine-rich  
(Ser-rich), Myt1 and coiled-coil domains and the CCHC-type zinc-fingers 
(ZF). Also shown is the predicted antigenicity and the conservation 
between the proteins generated using EpiC and T-Coffee, respectively. 
Based on these data, a fragment of mmMyt1l (amino acids 171–420) 
was used as an antigen for antibody induction in rabbits. The sequence 
identities among the antigen regions and the full-length proteins and their 
molecular masses are shown (right). b–d, Western blots of MEF cells upon 
induction of Flag-tagged mmMyt1l (b), HEK293 cells upon transfection 
of Flag-tagged mmMyt1, mmMyt1l, St18, and untagged hsMyt1l (c), and 
E13.5 embryonic mouse whole brain lysate using preimmune serum and 
antibodies against Myt1l, Flag, and tubulin (d). e, Microscopy images 
of HEK293 cells upon transfection of Flag-tagged mmMyt1l followed 
by immunofluorescence using antibodies against Flag (red) and Myt1l 
(green). f, Microscopy images of a section from adult mouse cortex upon 
immunofluorescence using antibodies against NeuN (red) and Myt1l 
(green), and DAPI staining (blue). Scale bar, 10 μ m. g, Myt1l antibody 
specifically marks mouse brain neurons in vivo. Immunofluorescence 
microscopy images of adult mouse brain cortex sections using antibodies 
against neuron-specific NeuN and Map2 or oligodendrocyte-specific 
Olig2 and Apc. Astrocytes (Gfap) and microglia (Iba1) are shown in red 
with Myt1l (green) and DAPI staining (blue). Note that Myt1l overlaps 
only with neuronal markers. Scale bar, 20 μ m.
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Extended Data Figure 2 | See next page for caption.
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Extended Data Figure 2 | Genome-wide chromatin binding of Myt1l.  
a, b, ChIP of endogenous Myt1l from E13.5 mouse brain (a) or of  
wild-type Myt1l (b, left) and Myt1l200–623 (b, right) transgenes from 
MEF cell lysates 2 days after induction with or without Ascl1 and Brn2. 
Chromatin immunoprecipitates were analysed by western blotting 
with Myt1l, Brn2, and Ascl1 antibodies. Input, 0.3% of ChIP input; 
unbound, 0.3% of ChIP flow-through; ChIP, 3% of ChIP eluates.  
c, ChIP–seq genome-wide occupancy of endogenous Myt1l in E13.5 
mouse brains (n = 2) or Myt1l and Myt1200–623 in MEFs two days after 
induction with (n = 3) or without (n = 2) Ascl1 and Brn2. A total of 6,911 
peaks are sorted on the basis of intensity and corresponding genomic 
regions are displayed across all datasets; signal is displayed ± 2 kb from 
summits (see also Fig. 1). d, Chromatin reads for Myt1l, Ascl1 and Brn2 
at Ascl1 (top) and Brn2 peaks (bottom)8. e, Chromatin reads of indicated 
histone marks in uninfected MEFs at the sites at which Myt1l is bound 
during reprogramming. Signal is displayed ± 2 kb from peak summit.  
f, Pearson correlation and clustering analysis of ChIP–seq samples 
highlight high binding overlap between different conditions. g, MA plots 
from DiffBind and corresponding Venn diagrams showing the distribution 
of Myt1l ChIP–seq peak intensities between indicated conditions; 
endogenous Myt1l in mouse brain versus overexpressed Myt1l in BAM 
MEFs (top), Myt1l overexpression alone versus in combination with 
Ascl1 and Brn2 (BAM) in MEFs (bottom left), and wild-type Myt1l versus 
Myt1l200–623 overexpression in MEFs (bottom right). Significantly different 
peaks are shown in colour and numbers are annotated. Peaks that are 
significantly changed by the experimental setup are highlighted red.
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Extended Data Figure 3 | See next page for caption.
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Extended Data Figure 3 | Myt1l represses many genes but not the 
neuronal transcriptional network. a, Heatmap of gene expression 
changes at promoter-bound Myt1l target genes during iN cell conversion 
of MEFs at the indicated time points based on RNA-seq show significant 
enrichment of Myt1l motifs at repressed genes (P = 6.85 × 10−6), n = 2 
(ref. 8) (left) and inverse transcriptional effects upon Myt1l knockdown 
in primary hippocampal neurons (right). b, Mean expression of selected 
Myt1l target genes in MEFs upon induction of wild-type Myt1l together 
with Ascl1 for two days determined by quantitative real-time PCR show 
significant repression of canonical inhibitors of neurogenesis by Myt1l. 
Names and annotated functions of tested genes are indicated, expression 
levels were normalized to Ascl1-only induction and GAPDH expression, 
n = 4 biological replicates (with 2 technical replicates each). Error bars 
show s.e.m., pair wise fixed reallocation randomization test * P < 0.001 
(ref. 51). c, Myt1l ChIP–seq profile at the Hes1 and Ncam1 promoter 
shows strong binding of endogenous Myt1l in E13.5 mouse brain and 
overexpressed wild-type Myt1l in MEFs two days after reprogramming; 
red bars mark multiple Myt1l AAGTTT motifs present in repressed Hes1 
promoter and gene body. d, Overlap of Myt1l-bound target genes that 
are induced or repressed during conversion of MEFs into iN cells upon 
overexpression of Myt1l with or without Ascl1 and Brn2 and indicated 
cell type-specific expression signatures determined by GeneOverlap50. 
Odds ratio > 2 represents strong association, P values are shown in 
brackets; n.s., not significant. e, Selected top gene ontology (GO) terms of 
Myt1l-targeted genes that are repressed (top) or induced (bottom) during 
reprogramming determined by PANTHER33. Enrichment scores and  
P values are shown. Highlighted are the terms ‘negative regulation of 
neuron differentiation’ (green) in the repressed cluster and ‘generation 
of neurons’ (red) in the induced cluster. Both analyses show a striking 
enrichment of repressed Myt1l target genes within several non-neuronal 
programs. Of note, several metabolic GO terms are among the upregulated 
target genes.
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Extended Data Figure 4 | Myt1l blocks muscle differentiation in 
primary myoblasts. a, Representative micrographs of muscle cells 
derived from primary myoblasts upon differentiation for 4 days with with 
rtTA alone (mock) or in combination with wild-type Myt1l followed by 
immunofluorescence using antibodies against Myh (green), Myt1l (red) 
and DAPI staining (blue); scale bar, 100 μ m. b, Muscle differentiation 
efficiency of cells shown in a highlight the repressive effect of Myt1l 
expression (+ ) on Myh-induction compared to Myt1l-negative cells (− ). 
n = 3, error bars show s.e.m., t-test * P < 0.005. c, Western blot of muscle 
cells shown in a using indicated antibodies shows reduction of several 
muscle markers upon Myt1l overexpression.
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
Letter reSeArCH
Extended Data Figure 5 | See next page for caption.
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Extended Data Figure 5 | Truncation screen identifies minimal 
neurogenic domains of Myt1l. a, Schematic of Flag- and NLS-tagged 
Myt1l truncation proteins including amino acid positions. Ability to 
enhance neurogenic conversion together with Ascl1 is indicated by  
(+ ), minimal active truncation Myt1l200–623 is boxed red (see also Fig. 3). 
Myt1l truncations with partial or without enhanced conversion activity are 
indicated with (+ /− ) and (–), respectively. b, Representative micrographs 
of iN cells derived from MEFs upon reprogramming for 14 days with Ascl1 
together with the indicated transgenes followed by immunofluorescence 
using antibodies against TUJ1 (red) and DAPI staining (blue); scale bar, 
50 μ m. c–g, Electrophysiological characterization of iN cells derived in 
b upon maturation for 21 days on mouse glia. c, Representative action 
potential (AP) traces of iN cells upon reprogramming with Ascl1 together 
with indicated Myt1l truncation. Pie charts indicate fraction of cells firing 
single (grey), multiple (white), or no (black) action potentials.  
d, Mean number of action potentials fired plotted with respect to pulse 
amplitude measured at − 60 mV holding potential. e, Mean resting 
membrane-potential (Vrest). f, g, Mean membrane resistance (Rm; f) 
and capacitance (Cm; g) measured at − 70 mV holding potential. Dotted 
line indicates intrinsic properties of Ascl1 + GFP cells; n = 3 biological 
replicates (total number of individual cells measured indicated), error 
bars show s.e.m., t-test * P < 0.05. h, Microscopy images showing nuclear 
localization of all tested Myt1l truncations 2 days after induction in MEFs 
by immunofluorescence using antibodies against Flag (grey) and DAPI 
staining (blue), scale bar 10 μ m. i, Western blot analysis of HEK293 cells 
2 days after transfection with the indicated transgenes confirms protein 
integrity using antibodies against Flag and tubulin.
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Extended Data Figure 6 | Characterization of mouse and human iN 
cells generated with Ascl1 and Myt1l. a, Microscopy images of iN cells 
derived from MEFs upon reprogramming for 21 days on mouse glia by 
overexpression of Ascl1 together with either wild-type Myt1l or  
Myt1l200–623 followed by immunofluorescence using antibodies against 
Map2 (red) and synapsin (green) or NeuN (red) and Tau–eGFP (green), 
scale bar 10 μ m. b, Synaptic recordings of Tau–eGFP-positive mouse iN 
cells shown in a. c, d, Spontaneous and evoked EPSCs were recorded 
at a holding potential of − 70 mV (blue) and blocked by the addition 
of CNQX (red), indicating that the excitatory nature of the resulting 
induced neurons is mediated through AMPA-type receptors (AMPARs). 
e, Immunofluorescence images of iN cells derived from human embryonic 
fibroblasts upon reprogramming for 6 weeks by overexpression of GFP, 
Ascl1, Ngn2 and Brn2 together with either wild-type Myt1l or Myt1l200–623 
and co-culture with primary cortical mouse neurons using antibodies 
against synapsin (red) and GFP (green); scale bar,10 μ m. f, Synaptic 
recordings of GFP-positive human iN cells shown in e. g, h, Spontaneous 
and evoked EPSCs were recorded at a holding potential of − 70 mV, 
indicating synaptic competence of the resulting induced human neurons. 
n = 4 cells (fraction of active cells indicated).
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Extended Data Figure 7 | Zinc-fingers are essential for neurogenic 
function of Myt1l. a, Schematic of Myt1l zinc-finger 2–3 point and 
deletion mutants. The ability to enhance neurogenic conversion together 
with Ascl1 is indicated by (+ ), non-functional mutants are indicated with 
(− ) (see also Fig. 3). b, Sequence alignments and conservation of CCHC-
type zinc-fingers from Myt1l; cysteine and histidine residues that can 
coordinate Zn(II) are highlighted in purple, non-coordinating mutated 
histidines are shown in green. c, Representative immunofluorescence of  
iN cells derived from MEFs upon reprogramming for 14 days with Ascl1 
and the indicated transgenes; TUJ1 (red), DAPI staining (blue), scale bar,  
50 μ m. d–h, Electrophysiological characterization of iN cells derived in 
c upon maturation for 21 days on mouse glia. d, Representative action 
potential (AP) traces of iN cells generated with indicated transgenes;  
pie charts indicate fraction of cells firing single (grey), multiple (white),  
or no (black) action potentials. e, Mean number of action potentials  
fired plotted with respect to pulse amplitude measured at − 60 mV  
holding potential. f, Mean resting membrane potential (Vrest).  
g, h, Mean membrane resistance (Rm; g) and capacitance (Cm; h) measured 
at − 70 mV holding potential. Dotted line indicates intrinsic properties 
of Ascl1 + wild-type Myt1l or Ascl1 + Myt1l200–912 cells; n = 3 biological 
replicates (total number of individual cells measured indicated), error 
bars show s.e.m., t-test * P < 0.05.
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Extended Data Figure 8 | Sin3b binds Myt1l via N-terminal SID 
domains and is essential for reprogramming. a, Schematic of FLAG  
and NLS-tagged Myt1l truncations and GST-tagged Myt1l fusion  
proteins. Putative SIN3 interaction domains (SIDs) are highlighted  
(see also Fig. 3). Ability and inability to interact biochemically with Sin3b 
are indicated by (+ ) and (− ), respectively. b, GST bait loading after pull 
down was controlled by Ponceau staining of the western blot membrane. 
Input, 0.2% of pull down input; pull down lanes, 20% of pull down eluates. 
c, ChIP–seq tracks of Sin3b, HDAC1, and Myt1l show binding at the 
Hes1 promoter 2 days after MEF reprogramming with Ascl1, Brn2 and 
wild-type Myt1l. Vertical bars mark Myt1l AAGTT motifs. d, Multiple 
sequence alignments of the highly conserved putative SIDs within 
minimal functional region of Myt1l from selected eukaryotic species. 
The alignment was generated using T-Coffee and putative SID regions 
are shown above the alignment. e, Western blot of iN cells derived from 
MEFs upon reprogramming for 2 days with Ascl1 and wild-type Myt1l 
together with either control or Sin3b-targeting shRNA constructs using 
indicated antibodies. f, Representative micrographs of iN cells derived 
in e upon reprogramming for 14 days followed by immunofluorescence 
using antibodies against TUJ1 (red) and DAPI staining (blue); scale bar, 
50 μ m. g, Conversion efficiency of cells shown in f based on TUJ1-positive 
cells with neuronal morphology highlight the deleterious effect of Sin3b 
knockdown on iN cell formation. n = 3, error bars show s.e.m., t-test  
* P < 0.005.
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Extended Data Figure 9 | Myt1l acts upstream of Hes1 to repress 
Notch signalling and stabilize Ascl1. a, Immunofluorescence of iN cells 
quantified in Fig. 4a derived from MEFs upon reprogramming for 7 days 
with Ascl1 and wild-type Myt1l, NICD or a combination; TUJ1 (red), 
Tau–eGFP (green), DAPI staining (blue); scale bar, 50 μ m. b, Neurogenic 
conversion efficiency of MEF cells upon reprogramming for 7 days with 
Ascl1 together with either wild-type Myt1l (n = 6), Hes1 (n = 3) or a 
combination of indicated transgenes or upon treatment with DAPT  
(10 μ M) (n = 3) based on Tau–eGFP induction determined by flow 
cytometry. Dotted line indicates mean conversion efficiency of 
Ascl1 + Myt1l cells; error bars show s.d., t-test * P < 0.05. c, Western blot 
analysis of cells shown in a and b after 2 days of reprogramming and 
mouse NSCs using indicated antibodies shows no striking induction of 
the neural stem-cell markers nestin, Pax6 (arrowhead) or Sox1 in any 
condition but strong reduction of Ascl1 upon Hes1 overexpression.  
d, Mean expression levels of endogenous and exogenous (overexpressed) 
Ascl1 transcripts in MEFs upon overexpression of Ascl1 and Hes1 with 
or without wild-type Myt1l for 2 days determined by quantitative real 
time PCR show significant repression of both endogenous and exogenous 
Ascl1 by Hes1 overexpression independent of Myt1l. Expression levels 
were normalized to Ascl1 only induction and GAPDH expression. 
n = 4 biological replicates (with 4 technical replicates each), error 
bars show s.e.m., pair-wise fixed reallocation randomization test  
* P < 0.001 (ref. 51). e, Western blot analysis of MEF cells upon induction 
of Ascl1 together with GFP, wild-type Myt1l or Myt1l200–623 after 0, 2, 
5 and 7 days of reprogramming using antibodies against Myt1l, Ascl1, 
GFP and tubulin shows no striking induction of full-length Myt1l upon 
overexpression of minimal fragment but stabilization of Ascl1 levels. 
f, Immunofluorescence of neurons quantified in Fig. 4c derived from 
mouse NSCs upon differentiation for 7 days with rtTA alone (mock) 
or in combination with Myt1l200–623; TUJ1 (red), Myt1l (green), DAPI 
staining (blue), scale bar 50 μ m. Of note, all neurons formed in the control 
condition expressed endogenous Myt1l.
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Extended Data Figure 10 | See next page for caption.
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Extended Data Figure 10 | Myt1l maintains neuronal identity by 
repression of non-neuronal programs. a, Myt1l knockdown in  
P0 mouse primary hippocampal neuronal cultures impairs neuronal 
maturation and maintenance. Cells were infected with shRNA-expressing 
lentivirus on third day of in vitro culture and analysed 11 days later by 
quantitative western blot using indicated antibodies. While tubulin served 
as loading control, several neuronal markers were severely downregulated 
by Myt1l depletion. Representative western blot images are shown, 
n = 5, error bars show s.e.m., t-test * P < 0.05. b–f, Electrophysiological 
characterization of Myt1l knockdown neurons derived in a.  
b, Representative action potential (AP) traces of hippocampal neurons  
upon indicated knockdown; pie charts indicate fraction of cells firing 
single (grey), multiple (white), or no (black) action potentials at the  
90 pA pulse. c, Mean number of action potentials fired, plotted with 
respect to pulse amplitude measured at − 60 mV holding potential.  
d, Mean resting membrane-potential (Vrest). e, f, Mean membrane 
resistance (Rm; e) and capacitance (Cm; f) measured at − 70 mV holding 
potential. Dotted line indicates intrinsic properties upon control shRNA 
treatment. n = 5 biological replicates (total number of individual cells 
measured indicated), error bars show s.e.m., t-test * P < 0.05. g, Myt1l  
knockdown in P0 mouse primary hippocampal neuronal cultures induces 
non-neuronal gene expression programs. Overlap of Myt1l-bound 
target genes that are induced or repressed upon knock down of Myt1l in 
primary hippocampal neurons and indicated cell type-specific expression 
signatures determined by GeneOverlap50. Odds ratio > 2 represents 
strong association, P values are shown; n.s., not significant. h, Relative 
number of Myt1l and REST DNA binding motifs at cell type specific-
genes highlight depletion of Myt1l and enrichment of REST motifs at 
neuronal genes (t-test * P < 0.005). i, RNA–seq analysis of genes shown in 
a, confirm decreased expression of neuronal genes upon Myt1l depletion. 
In addition several Notch and Wnt signalling factors that are direct targets 
of Myt1l are de-repressed (see also Fig. 2c). In addition, transcription 
of several non-neuronal lineage specifiers is induced compared to the 
control. Shown are gene expression values of cells treated as in a based 
on RNA–seq; fold change is represented in logarithmic scale normalized 
to the control shRNA-treated sample, n = 2. j, Selected top gene ontology 
(GO) terms of Myt1l-targeted genes that are repressed (top) or induced 
(bottom) upon knock down in primary hippocampal neurons determined 
by PANTHER33. Enrichment scores and P values are shown. Highlighted 
are the terms ‘generation of neurons’ (green) in the repressed cluster and 
‘negative regulation of neurogenesis’ (red) in the induced cluster.  
In addition this analysis highlights induction of several non-neuronal  
gene expression programs upon Myt1l depletion.
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